» Articles » PMID: 11867564

Expression and Function of 4-1BB and 4-1BB Ligand on Murine Dendritic Cells

Overview
Journal Int Immunol
Date 2002 Feb 28
PMID 11867564
Citations 95
Authors
Affiliations
Soon will be listed here.
Abstract

4-1BB (CDw137) and its ligand (4-1BBL) have been implicated in cellular immune responses. To further characterize the expression and function of 4-1BBL, we newly generated an anti-mouse 4-1BBL mAb (TKS-1), which can inhibit the interaction of 4-1BBL with 4-1BB. Flow cytometric analyses using TKS-1 and an anti-mouse 4-1BB mAb indicated that 4-1BB was inducible on both CD4(+) and CD8(+) splenic T cells by stimulation with immobilized anti-CD3 mAb, but 4-1BBL was not expressed on resting or activated T cells. 4-1BBL expression was inducible on splenic B cells by stimulation with anti-IgM antibody plus anti-CD40 mAb, on peritoneal macrophages by stimulation with lipopolysaccharide (LPS) and on splenic dendritic cells (DC) by stimulation with anti-CD40 mAb or LPS. Interestingly, splenic DC expressed 4-1BB constitutively, which was down-regulated by anti-CD40 stimulation. Co-culture of splenic DC with 4-1BBL-transfected cells or 4-1BBL-expressing tumor cell lines led to cytokine (IL-6 and IL-12) production and co-stimulatory molecule up-regulation by splenic DC, indicating that 4-1BBL can directly activate DC. Moreover, IL-12 production by anti-CD40-stimulated DC was partially inhibited by TKS-1. These results suggest that 4-1BB expressed on DC may be involved in DC activation through DC--tumor interaction and DC--DC interaction.

Citing Articles

Oncolytic vaccinia virus armed with 4-1BBL elicits potent and safe antitumor immunity and enhances the therapeutic efficiency of PD-1/PD-L1 blockade in a pancreatic cancer model.

Ju Y, Dai F, Wang Y, Ye Z, Li Y, Ju S Transl Oncol. 2024; 50():102151.

PMID: 39388958 PMC: 11736404. DOI: 10.1016/j.tranon.2024.102151.


Tumor necrosis factor superfamily signaling: life and death in cancer.

Ababneh O, Nishizaki D, Kato S, Kurzrock R Cancer Metastasis Rev. 2024; 43(4):1137-1163.

PMID: 39363128 PMC: 11554763. DOI: 10.1007/s10555-024-10206-6.


Oncolytic Adenovirus Armed with a Novel Agonist of the CD137 Immune Checkpoint Stimulator Suppresses Tumor Growth.

Ramos-Gonzalez M, Tarique M, Batra L, Arguc F, Garza-Morales R, Shirwan H Vaccines (Basel). 2024; 12(3).

PMID: 38543974 PMC: 10974162. DOI: 10.3390/vaccines12030340.


4-1BB immunotherapy: advances and hurdles.

Singh R, Kim Y, Lee S, Eom H, Choi B Exp Mol Med. 2024; 56(1):32-39.

PMID: 38172595 PMC: 10834507. DOI: 10.1038/s12276-023-01136-4.


A time-resolved meta-analysis of consensus gene expression profiles during human T-cell activation.

Rade M, Bohlen S, Neuhaus V, Loffler D, Blumert C, Merz M Genome Biol. 2023; 24(1):287.

PMID: 38098113 PMC: 10722659. DOI: 10.1186/s13059-023-03120-7.